Insights and events
David Schreiber assists medical device clients with regulatory matters. Prior to joining Hogan Lovells, David was a Senior Life-Science Grant Consultant at FreeMind. The FreeMind Group specializes in non-dilutive life science consulting, and is the largest consulting group of its kind, working with academics and industry alike.
As a grant consultant, David specialized in obtaining non-dilutive funding for clients through U.S. federal agencies (National Institutes of Health, United States Department of Defense, and others). Taking a strategic, funding agency-oriented approach, David managed over 50 major multi-team international grant projects across all areas of medical device and drug development, and secured millions of dollars in project funding for his clients.
At FreeMind, David was also a Professional Leader for all clinical proposals. David is CRA-qualified and familiar with regulatory and practical aspects of clinical study design and management. He was the authority at departmental level when it came to clinical projects and related regulation.
A critical reviewer, David loves to dive into a project, familiarize himself with new concepts and provide valued, content-related feedback, while paying great attention to details.
David is fluent in multiple languages including English, French, Hebrew and Dutch, and proficient in German. This often helps him in better connecting with European and Israeli clients.
- M.Sc., The Weizmann Institute of Science, 2016